Introduction During the past half century there has been major progress in the scientific understanding of cardiovascular conditions in children and youth, and this progress has led to improved prevention and treatment of congenital and acquired heart disease. Following this period of advancement, the current status of our understanding should be reviewed to create a foundation for future scientific efforts.
The focus of research and clinical activity in cardiac disease in children has changed during the past 60 years. In the 1930s the major concern among cardiologists caring for children was rheumatic fever and rheumatic heart disease. Interest in congenital heart disease was just beginning. In the 1940s extracardiac operations for cardiac malformations were developed, and in the 1950s the first open-heart procedures involving cardiopulmonary bypass were performed. In the 1960s and 1970s cardiopulmonary bypass became more widely available, and the pediatric patient group undergoing open-heart procedures was expanded from children to neonates and infants. In the 1970s and 1980s, echocardiography and therapeutic catheterization techniques were used in children with cardiac abnormalities. During the past two decades, two other major areas of emphasis have developed: electrophysiology, which allows improved diagnosis and management of arrhythmias in children, and cardiovascular risk factor evaluation in children. In addition, pediatric cardiologists now recognize the need to slow the development of atherosclerosis, a process that often begins in childhood.
As the 20th century draws to a close, it is appropriate to review the status of both the major cardiovascular diseases of children and the cardiovascular health of children and youth. This report also describes barriers to continued progress in this important area of cardiovascular medicine, and should help direct research, educational, and other efforts by individuals and organizations interested in cardiovascular disease and the health of children.
Current Status of Children's Cardiovascular Health
Cardiovascular disease occurs more often in children than is generally appreciated by health care professionals or the general public. More Paroxysmal tachycardia can be due to several mechanisms. At least three children per 1000 without a structural anomaly of the heart have symptomatic tachycardia. Wolff-Parkinson-White syndrome occurs in one to three people per 1000,41 and a similar proportion of the population has concealed preexcitation. Half of these people are symptomatic, so two people per 1000 (including children) have symptoms of a preexcitation mechanism. About one child per 1000 has paroxysmal tachycardia from atrioventricular nodal reentry. In addition, a small number of children have tachycardia from another mechanism.
Abnormally slow heart rate is usually due to complete heart block. It occurs in one per 20 000 children without structural abnormality of the heart and in one per 1000 with a cardiac malformation.42 Maternal lupus erythematosus is the cause in some infants and children. Rarely, a slow heart rate occurs secondary to conditions such as polymyositis, myocarditis, or Kearns-Sayer syndrome.
Syncope is a common symptom in children that may prompt a cardiac evaluation because it may be related to an intrinsic cardiac condition. Perhaps 15% of children have at least one syncopal episode,43 with few having an underlying cardiac anomaly or a second episode. Tilt-table testing in patients with true syncope often discloses a vasodepressor origin that can be successfully treated with fluid loading or beta-blockade.
Sudden death during childhood is uncommon, occurring 2.5 to 8.5 times per 100 000 patient-years. 44 Among the causes is the prolonged QT interval syndrome, for which a genetic abnormality has been described.
Cardiac rhythm disturbances occur secondary to cardiac operations and are believed to be the cause of sudden death in some patients years after surgery. The recorded incidence of this problem will probably increase as more patients are followed for longer periods after operation.
The successful treatment of cardiac rhythm disturbances awaits the development of new and more specific pharmacologic agents. In the case of the young this process is hindered by the 
Smoking
Tobacco use increases the risk of coronary heart disease and other atherosclerotic disease and is a modifiable risk factor. The smoking habit is usually acquired during adolescence, and an estimated 4 000 000 adolescents smoke.63 Primary prevention programs against smoking have been created and are effective,6465 but methods of implementing programs also need to be developed. The tobacco industry has directed strong, successful advertising toward children, as well as residents of poorer urban areas,6667 with the result that major changes in market share resulting from cigarette advertising have occurred primarily in younger smokers. 68 Children's health is also adversely affected by environmental smoke. 69 Respiratory diseases and asthma occur more frequently in households in which parents smoke. Neonates who are small for gestational age are more likely to be born to mothers who smoke than to nonsmoking mothers. The increased cardiovascular risk of adults exposed to secondary cigarette smoke is well documented.70 The AHA and the Environmental Protection Agency have indicated that environmental tobacco smoke is a health hazard. 71 Although education has some effect on modification of the smoking habit, public policy approaches are much more effective in reducing cigarette smoking by adolescents. The excise tax on a pack of cigarettes in Canada is $3, and with the implementation of this level of taxation the number of adolescents in Canada who began smoking was reduced by two thirds.72 The recent passage of Proposition 99 in California, in which the excise tax was increased by 25¢ to 35¢ per pack, was associated with a 13.8% reduction in the number of smokers. 73 The price elasticity of cigarettes could be a major weapon against acquisition of the cigarette smoking habit by adolescents. Other major public policy efforts must be directed at the advertising, promotion, sales, and distribution of tobacco products. Cigarettes are still not regulated by the major congressional health and safety acts, acts that regulate other products such as food, drugs, and cosmetics. and sex-specific percentiles of blood pressure measurements from birth to 18 years.80 "Normal" blood pressure is systolic and diastolic blood pressures less than the 90th percentile, "high normal" blood pressure is average systolic and/or average diastolic blood pressure between the 90th and 95th percentiles, "high" blood pressure (significant hypertension) is average systolic and/or diastolic pressure greater than or equal to the 95th percentile (with measurements obtained on at least three occasions), and "severe" hypertension is average systolic and/or average diastolic blood pressure above the 99th percentile. If a child has high blood pressure, nonpharmacologic therapies should be instituted first. These include dietary intervention, weight control, and physical activity. Pharmacologic therapy always has some side effects and therefore should be reserved for children whose blood pressure cannot be controlled by rigorous nonpharmacologic measures. Because no studies have been done of the long-term efficacy or safety of blood pressure lowering in childhood by hygienic or pharmacologic methods, such studies are urgently required.
Barriers to Progress in Cardiovascular Disease
Prevention in Children and Youth There are barriers to optimum prevention and treatment of these conditions in children and youth. The AHA's Task Force on Children and Youth has described these barriers and outlined a series of recommendations and strategies to meet the challenges they impose.93 More research is needed, and research initiatives will be developed at scientific conferences designed to review critical areas of cardiac development and etiology of disease in children. Financial support for such research initiatives must be increased. Educational programs on cardiovascular risk factors will be extended to children and their families. When these programs are coordinated with efforts in the community and in schools, they will reduce the prevalence of cardiovascular risk factors. The task force recommends that various departments and committees of the AHA use their resources for the benefit of children: for example, by developing more research initiatives for funding by the AHA or NHLBI and increasing legislative and regulatory efforts in the areas such as mandadesirable health habits and health education is the tory school health programs and tobacco advertising.
It is hoped that in the next decade, through research and educational efforts, many advances in the prevention and treatment of cardiovascular diseases in the young will be realized.
